Caris Life Sciences, Inc.
CAI
$18.80
$0.331.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 81.96M | 24.33M | -71.79M | -102.58M | -36.95M |
| Total Depreciation and Amortization | 4.29M | 4.87M | 6.41M | 7.05M | 9.07M |
| Total Amortization of Deferred Charges | 605.00K | 2.46M | 7.76M | 1.95M | 1.91M |
| Total Other Non-Cash Items | 17.02M | 16.68M | 66.35M | 48.93M | -5.98M |
| Change in Net Operating Assets | -59.10M | 14.09M | -1.44M | 13.32M | -6.97M |
| Cash from Operations | 44.78M | 62.43M | 7.29M | -31.34M | -38.92M |
| Capital Expenditure | -5.09M | -7.10M | -1.39M | -2.69M | -2.29M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -5.09M | -7.10M | -1.39M | -2.69M | -2.29M |
| Total Debt Issued | 0.00 | 0.00 | 27.87M | -- | 0.00 |
| Total Debt Repaid | -39.00K | -23.00K | -22.00K | -22.00K | -21.00K |
| Issuance of Common Stock | 3.86M | 1.15M | 529.65M | 1.43M | 272.00K |
| Repurchase of Common Stock | -424.00K | -16.56M | -1.66M | -22.00K | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 121.24M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -5.67M | 4.33M | -105.00K | -25.00K |
| Cash from Financing | 3.40M | -21.10M | 681.40M | 1.29M | 226.00K |
| Foreign Exchange rate Adjustments | -29.00K | 62.00K | 93.00K | 4.00K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 43.06M | 34.30M | 687.40M | -32.74M | -40.99M |